Impella RP Flex with SmartAssist Receives FDA Approval to Treat Right Heart Failure

Oct 31, 2022 | Industry Press Releases

Danvers, Mass., October 31, 2022 – Abiomed (Nasdaq: ABMD) announces that Impella RP Flex with SmartAssist has received U.S. Food and Drug Administration (FDA) pre-market approval (PMA), the FDA’s highest level of approval, as safe and effective to treat acute right heart failure for up to 14 days.

X